Abstract
Therapeutic apheresis is an extracorporeal treatment that selectively removes abnormal
cells or harmful substances in the blood that are associated with or cause certain
diseases. During the last decades the application of therapeutic apheresis has expanded
to a broad spectrum of hematological and non-hematological diseases due to various
studies on the clinical efficacy of this procedure. In this context there are more
than 30 centers performing therapeutic apheresis and registered in the apheresis database
in Turkey. Herein, we, The Turkish Apheresis Registry, aimed to analyze some key articles
published so far from Turkey regarding the use of apheresis for various indications.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Transfusion and Apheresis ScienceAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Therapeutic plasma apheresis: expertise and indications.Transfus Apher Sci. 2019; 58: 254-257
- Indications for therapeutic apheresis in hematological disorders.Semin Hematol. 2020; 57: 57-64
- Conventional apheresis therapies: a review.J Clin Apher. 2011; 26: 230-238
- The role of extracorporeal photopheresis in chronic graft-versus-host disease.Transfus Apher Sci. 2015; 52: 157-161
- The 2019 guidelines from the American Society for Apheresis: what's new?.Curr Opin Hematol. 2019; 26: 461-465
- Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.Transfus Apher Sci. 2013; 48: 353-358
- Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study.Transfus Apher Sci. 2007; 36: 57-67
- The effect of therapeutic plasma exchange on management of HELLP syndrome: the report of 47 patients.Transfus Apher Sci. 2021; 60103248
- Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis.Transfus Apher Sci. 2013; 48: 349-352
- Efficacy and safety of plasmapheresis in symptomatic hyperviscosity and cast nephropathy: a multicenter experience in Turkey.Transfus Apher Sci. 2021; 60103244
- A multicenter retrospective analysis on therapeutic plasma exchange in immune thrombocytopenic purpura.Transfus Apher Sci. 2021; 60103246
- Apheresis in patients with sepsis: a multicenter retrospective study.Transfus Apher Sci. 2021; 60103239
- The effect of HA330 hemoperfusion adsorbent method on inflammatory markers and end-organ damage levels in sepsis: a retrospective single center study.Eur Rev Med Pharmacol Sci. 2022; 26: 8112-8117
- Efficacy of therapeutic plasma exchange in patients with Crimean-Congo hemorrhagic fever.J Clin Apher. 2021; 36: 390-397
- Therapeutic plasma exchange for envenomation: is it reasonable?.Transfus Apher Sci. 2021; 60103241
- Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma - single center experience.Transfus Apher Sci. 2021; 60103127
- An innovation in stem cell harvesting: Heparin use.Transfus Apher Sci. 2021; 60103240
- Hematopoietic progenitor cell mobilization.Transfus Apher Sci. 2017; 56: 787
- Inferior prognosis in poor mobilizing myeloma patients.Transfus Apher Sci. 2020; 59102722
- Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: a retrospective multicenter study.Transfus Apher Sci. 2021; 60103243
- Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: a multicenter experience.Transfus Apher Sci. 2021; 60103242
- Extracorporeal blood purification treatment options for COVID-19: the role of immunoadsorption.Transfus Apher Sci. 2020; 59102855
- Convalescent plasma therapy in patients with COVID-19.Transfus Apher Sci. 2021; 60102955https://doi.org/10.1016/j.transci.2020.102955
- The Turkish experience with therapeutic plasma exchange: a national survey.Transfus Apher Sci. 2019; 58: 287-292
Article info
Publication history
Published online: February 24, 2023
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
© 2023 Elsevier Ltd. All rights reserved.